U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 091673

Expand all

ATAZANAVIR SULFATE (ATAZANAVIR SULFATE)
EQ 100MG BASE
Marketing Status: Prescription
Active Ingredient: ATAZANAVIR SULFATE
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091673
Product Number: 001
Approval Date: Apr 22, 2014
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Prescription
Patent and Exclusivity Information
ATAZANAVIR SULFATE (ATAZANAVIR SULFATE)
EQ 150MG BASE
Marketing Status: Prescription
Active Ingredient: ATAZANAVIR SULFATE
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091673
Product Number: 002
Approval Date: Apr 22, 2014
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Prescription
Patent and Exclusivity Information
ATAZANAVIR SULFATE (ATAZANAVIR SULFATE)
EQ 200MG BASE
Marketing Status: Prescription
Active Ingredient: ATAZANAVIR SULFATE
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091673
Product Number: 003
Approval Date: Apr 22, 2014
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Prescription
Patent and Exclusivity Information
ATAZANAVIR SULFATE (ATAZANAVIR SULFATE)
EQ 300MG BASE
Marketing Status: Prescription
Active Ingredient: ATAZANAVIR SULFATE
Proprietary Name: ATAZANAVIR SULFATE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 300MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091673
Product Number: 004
Approval Date: Apr 22, 2014
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top